| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
GILD
Gilead Sciences
|
Jun 18, 2026 | BUY |
Strong Buy
-4.8% avg upside
66 analysts
|
$177.00
42.95% Upside
|
+0.0% |
|
TEVA
Teva Pharmaceutical
|
Jun 15, 2026 | BUY |
Buy
-6.8% avg upside
39 analysts
|
$40.00
27.10% Upside
|
-3.4% |
|
JNJ
Johnson & Johnson
|
Jun 09, 2026 | BUY |
Strong Buy
-3.6% avg upside
36 analysts
|
$265.00
16.00% Upside
|
-0.8% |
|
MRK
Merck & Company
|
Jun 02, 2026 | BUY |
Strong Buy
+10.7% avg upside
43 analysts
|
$136.00
19.47% Upside
|
+0.5% |
|
BMY
Bristol-Myers Squibb
|
Jun 01, 2026 | HOLD |
Buy
+9.1% avg upside
42 analysts
|
$60.00
11.10% Upside
|
+0.6% |
|
PFE
Pfizer
|
May 28, 2026 | BUY |
Buy
+34.1% avg upside
45 analysts
|
$30.00
19.05% Upside
|
-3.6% |
|
REGN
Regeneron
|
May 19, 2026 | HOLD |
Strong Buy
+26.9% avg upside
57 analysts
|
$770.00
26.30% Upside
|
-3.4% |
|
VRTX
Vertex Pharmaceuticals
|
May 05, 2026 | BUY |
Strong Buy
-2.7% avg upside
61 analysts
|
$558.00
23.48% Upside
|
+8.2% |
|
AMGN
Amgen
|
May 01, 2026 | BUY |
Buy
-11.6% avg upside
57 analysts
|
$385.00
13.96% Upside
|
+6.3% |
|
ABBV
AbbVie
|
Apr 30, 2026 | BUY |
Buy
+2.8% avg upside
43 analysts
|
$280.00
29.38% Upside
|
+4.7% |
|
LLY
Eli Lilly & Co
|
Apr 28, 2026 | BUY |
Strong Buy
-10.5% avg upside
47 analysts
|
$1300.00
18.30% Upside
|
+25.9% |
|
INVA
Innoviva
|
Aug 07, 2025 | BUY |
Buy
+27.2% avg upside
12 analysts
|
$55.00
144.51% Upside
|
+22.6% |
|
SRPT
Sarepta Therapeutics
|
Aug 07, 2025 | BUY |
Buy
+246.5% avg upside
49 analysts
|
$80.00
356.34% Upside
|
-12.3% |
|
COGT
Cogent Biosciences
|
Aug 06, 2025 | BUY |
Strong Buy
+7.4% avg upside
26 analysts
|
$17.00
50.74% Downside
|
+212.0% |
|
ARDX
Ardelyx
|
Aug 05, 2025 | BUY |
Strong Buy
+124.7% avg upside
21 analysts
|
$15.00
147.94% Upside
|
+8.0% |
|
ACRS
Aclaris Therapeutics
|
Jul 30, 2025 | BUY |
Strong Buy
+122.9% avg upside
15 analysts
|
$9.00
99.95% Upside
|
+182.3% |
|
DYN
Dyne Therapeutics
|
Jul 29, 2025 | BUY |
Strong Buy
+93.5% avg upside
29 analysts
|
$50.00
152.60% Upside
|
+115.2% |
|
PTCT
PTC Therapeutics
|
Jul 29, 2025 | HOLD |
Buy
-1.4% avg upside
29 analysts
|
$55.00
30.27% Downside
|
+59.3% |
|
PVLA
Palvella Therapeutics
|
Jul 22, 2025 | BUY |
Strong Buy
+45.4% avg upside
27 analysts
|
$50.00
55.86% Downside
|
+214.2% |
|
CATX
Perspective Therapeutics
|
Jul 10, 2025 | BUY |
Strong Buy
+278.9% avg upside
22 analysts
|
$15.00
408.48% Upside
|
-28.7% |
|
GANX
Gain Therapeutics
|
Jul 09, 2025 | BUY |
Strong Buy
+318.8% avg upside
9 analysts
|
$12.00
538.26% Upside
|
+1.1% |
|
ZLAB
Zai Lab
|
Jul 02, 2025 | BUY |
Strong Buy
+223.0% avg upside
13 analysts
|
$55.00
202.46% Upside
|
-51.9% |
|
EWTX
Edgewise Therapeutics
|
Jun 27, 2025 | HOLD |
Strong Buy
+22.4% avg upside
14 analysts
|
$14.00
62.03% Downside
|
+157.8% |
|
SPRY
ARS Pharmaceuticals
|
May 15, 2025 | BUY |
Strong Buy
+121.7% avg upside
12 analysts
|
$30.00
210.81% Upside
|
-39.1% |
|
PCVX
Vaxcyte
|
Jan 28, 2025 | HOLD |
Strong Buy
+96.3% avg upside
15 analysts
|
— | -44.2% |
|
NVO
Novo Nordisk
|
Jan 28, 2025 | HOLD |
Buy
+168.1% avg upside
26 analysts
|
— | -27.2% |
|
ATOS
Atossa Therapeutics
|
Jan 03, 2025 | HOLD |
Strong Buy
+870.1% avg upside
6 analysts
|
— | -37.6% |
|
ANL
Adlai Nortye Ltd. Sponsored ADR
|
Jan 03, 2025 | HOLD |
Strong Buy
+113.6% avg upside
6 analysts
|
— | -40.0% |
|
LYRA
Lyra Therapeutics
|
Jan 03, 2025 | HOLD |
Hold
+3282.4% avg upside
7 analysts
|
— | -69.6% |
|
SPRO
Spero Therapeutics
|
Jan 03, 2025 | HOLD |
Buy
+501.5% avg upside
12 analysts
|
— | +113.6% |
|
PDSB
PDS Biotechnology
|
Jan 03, 2025 | HOLD |
Strong Buy
+1493.1% avg upside
11 analysts
|
— | -53.7% |
|
SCYX
SCYNEXIS
|
Jan 03, 2025 | HOLD |
Strong Buy
+225.1% avg upside
10 analysts
|
— | -54.6% |
|
ONCY
Oncolytics Biotech
|
Jan 03, 2025 | HOLD |
Strong Buy
+654.5% avg upside
12 analysts
|
— | +2.1% |
|
ZVRA
Zevra Therapeutics
|
Jun 10, 2024 | BUY |
Strong Buy
+85.5% avg upside
15 analysts
|
— | +100.0% |
|
ROIV
Roivant Sciences
|
May 30, 2024 | BUY |
Strong Buy
+2.5% avg upside
17 analysts
|
— | +5.8% |
|
EOLS
Evolus
|
Jan 16, 2024 | BUY |
Strong Buy
+116.3% avg upside
9 analysts
|
— | +1.7% |
|
IMVT
Immunovant
|
Oct 16, 2023 | BUY |
Strong Buy
+9.0% avg upside
24 analysts
|
$45.00
27.29% Upside
|
-22.7% |
|
MESO
Mesoblast
|
Aug 30, 2023 | BUY |
Strong Buy
+73.3% avg upside
14 analysts
|
$34.00
136.58% Upside
|
+135.7% |
|
TXMD
TherapeuticsMD
|
Aug 16, 2023 | HOLD |
Buy
+220.5% avg upside
8 analysts
|
$5.00
156.39% Upside
|
-54.6% |
|
CH:BSLN
Basilea Pharmaceutica
|
Aug 15, 2023 | BUY |
Strong Buy
+44.2% avg upside
6 analysts
|
$73.00
44.05% Upside
|
· |
|
EFTR
eFFECTOR Therapeutics
|
Aug 08, 2023 | BUY |
Strong Buy
+66249899.9% avg upside
5 analysts
|
$250.00
124999899.90% Upside
|
-99.7% |
|
ARQT
Arcutis Biotherapeutics
|
Aug 08, 2023 | BUY |
Strong Buy
+49.8% avg upside
14 analysts
|
$50.00
90.69% Upside
|
-9.0% |
|
HCM
HUTCHMED
|
Jul 24, 2023 | BUY |
Strong Buy
+208.7% avg upside
9 analysts
|
$50.00
386.35% Upside
|
+38.6% |
|
AMRN
Amarin
|
Jul 18, 2023 | BUY |
Buy
-47.2% avg upside
18 analysts
|
$5.00
68.79% Downside
|
-44.8% |
|
NBP
NovaBridge Biosciences
|
Jul 06, 2023 | BUY |
Strong Buy
+1306.0% avg upside
14 analysts
|
$25.00
1566.62% Upside
|
· |
|
VYNE
VYNE Therapeutics
|
May 12, 2023 | BUY |
Strong Buy
+2024.6% avg upside
9 analysts
|
$9.00
1316.36% Upside
|
-63.1% |
|
CFRXQ
ContraFect
|
Mar 17, 2023 | HOLD |
Buy
+10969999900.0% avg upside
10 analysts
|
— | · |
|
AVTX
Avalo Therapeutics
|
Feb 13, 2023 | HOLD |
Strong Buy
+265.1% avg upside
19 analysts
|
— | -99.3% |
|
ZTS
Zoetis
|
Nov 03, 2022 | BUY |
Buy
+71.4% avg upside
22 analysts
|
$250.00
217.57% Upside
|
+24.8% |
|
CNTB
Connect Biopharma Holdings
|
Jun 02, 2022 | BUY |
Strong Buy
+226.3% avg upside
11 analysts
|
$5.00
150.06% Upside
|
+54.4% |
|
ARDS
Aridis Pharmaceuticals
|
Dec 21, 2021 | BUY |
Strong Buy
+427319.4% avg upside
5 analysts
|
$18.00
580545.18% Upside
|
-62.9% |
|
RVLPQ
RVL Pharmaceuticals
|
Sep 24, 2021 | BUY |
Strong Buy
+624999900.0% avg upside
6 analysts
|
$6.00
599999900.01% Upside
|
-22.9% |
|
JAGX
Jaguar Animal Health
|
Sep 20, 2021 | BUY |
Strong Buy
+108.3% avg upside
5 analysts
|
$5.00
122.15% Upside
|
-91.6% |
|
EVFM
Evofem Biosciences
|
May 26, 2020 | BUY |
Buy
+269017.6% avg upside
8 analysts
|
$15.00
176370.50% Upside
|
· |
|
DE:MRK
Merck KGaA
|
Apr 29, 2020 | BUY |
Buy
+2.1% avg upside
32 analysts
|
$93.36
29.92% Downside
|
· |
|
VTRS
Viatris
|
Mar 25, 2020 | HOLD |
Buy
+48.2% avg upside
21 analysts
|
$22.00
43.23% Upside
|
-6.8% |
|
TBPH
Theravance Biopharma
|
Feb 25, 2020 | BUY |
Buy
+12.2% avg upside
18 analysts
|
$55.00
231.77% Upside
|
-24.9% |
|
PRGO
Perrigo Company
|
Jan 21, 2020 | BUY |
Buy
+565.5% avg upside
20 analysts
|
$70.00
582.94% Upside
|
-26.2% |
|
TSE:BHC
Bausch Health Companies
|
Jan 09, 2020 | BUY |
Buy
+783.6% avg upside
29 analysts
|
$50.92
655.58% Upside
|
· |
|
FR:ALCOX
Nicox SA
|
Dec 16, 2019 | BUY |
Strong Buy
+1599.7% avg upside
5 analysts
|
$12.00
3025.00% Upside
|
· |
|
ALDX
Aldeyra Therapeutics
|
Oct 22, 2019 | BUY |
Strong Buy
+716.1% avg upside
21 analysts
|
$33.00
1583.67% Upside
|
+27.4% |
|
AMRX
Amneal Pharmaceuticals
|
May 09, 2019 | BUY |
Strong Buy
+5.6% avg upside
18 analysts
|
$35.00
115.95% Upside
|
-67.8% |
|
OPK
Opko Health
|
Nov 09, 2018 | BUY |
Strong Buy
+374.3% avg upside
12 analysts
|
$20.00
1308.50% Upside
|
-52.4% |
|
HRTX
Heron Therapeutics
|
Sep 27, 2018 | BUY |
Strong Buy
+6439.5% avg upside
21 analysts
|
$50.00
11876.12% Upside
|
-37.5% |
|
TLPH
Talphera
|
Sep 25, 2018 | BUY |
Buy
+339.6% avg upside
15 analysts
|
— | -44.8% |
|
NBRVF
Nabriva Therapeutics
|
Jul 24, 2018 | BUY |
Buy
+13374900.0% avg upside
9 analysts
|
$16.00
15999899.98% Upside
|
· |
|
XFOR
X4 Pharmaceuticals
|
Jun 28, 2018 | BUY |
Strong Buy
+496.4% avg upside
15 analysts
|
$26.00
516.06% Upside
|
-37.5% |
|
JAZZ
Jazz Pharmaceuticals
|
Apr 06, 2017 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
— | -2.6% |
|
ANIP
ANI Pharmaceuticals
|
Apr 05, 2017 | BUY |
Strong Buy
+28.6% avg upside
11 analysts
|
$80.00
0.54% Upside
|
+22.9% |
|
XENE
Xenon
|
Sep 26, 2016 | BUY |
Strong Buy
+19.0% avg upside
28 analysts
|
$20.00
62.15% Downside
|
· |
|
PAHC
Phibro Animal Health
|
Jun 24, 2015 | BUY |
Hold
+17.0% avg upside
10 analysts
|
$45.00
41.37% Upside
|
-47.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.